Disclosures for "ARGUS: A Study of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Participants with Dravet Syndrome (DS): Preliminary Results from the Open-label Extension Phase"
-
Dr. Ray has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Ray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Ray has or had stock in Harmony Biosciences.
-
Sookyong Koh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science, Inc. Sookyong Koh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Sookyong Koh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier .
-
Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seizure. The institution of Dr. Donner has received research support from SickKids Centre for Brain and Mental Health. The institution of Dr. Donner has received research support from Ontario Brain Institute. The institution of Dr. Donner has received research support from CIHR.
-
Dr. Aungaroon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. The institution of Dr. Aungaroon has received research support from Biocodex. The institution of Dr. Aungaroon has received research support from UCB. The institution of Dr. Aungaroon has received research support from Eysz. The institution of Dr. Aungaroon has received research support from Epygenix.
-
Mrs. Rapchak has received personal compensation for serving as an employee of Harmony Biosciences. Mrs. Rapchak has stock in Harmony Biosciences.
-
Mrs. Mason has nothing to disclose.
-
Prof. Baraban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences.
-
Dr. Albers has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Albers has stock in Harmony Biosciences.
-
Kumar Budur, MD has received personal compensation for serving as an employee of Harmony Biosciences. Kumar Budur, MD has stock in Abbvie.